Home > Insider Trading > Filing (0001410442-21-000002)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
883984	Icu Medical Inc	ICUI	Surgical & Medical Instruments & Apparatus (3841)	330022692

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1410442	Vivek Jain	951 Calle Amanecer San Clemente CA 92673	Chairman And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-01-06	13,366	$58.79	79,607	No	4	M	Direct
Common Stock	Acquisiton	2021-01-06	10,973	$58.79	90,580	No	4	M	Direct
Common Stock	Disposition	2021-01-06	24,339	$220.00	66,241	No	4	S	Direct
Common Stock	Acquisiton	2021-01-07	6,070	$58.79	72,311	No	4	M	Direct
Common Stock	Disposition	2021-01-07	6,070	$220.00	66,241	No	4	S	Direct
Common Stock	Acquisiton	2021-01-08	38,591	$58.79	104,832	No	4	M	Direct
Common Stock	Disposition	2021-01-08	38,591	$220.00	66,241	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2021-01-06	13,366	$0.00	13,366	$58.79
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2021-01-06	10,973	$0.00	10,973	$58.79
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2021-01-07	6,070	$0.00	6,070	$58.79
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2021-01-08	38,591	$0.00	38,591	$58.79

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
400,000	2018-02-13	2024-02-24	No	4	M	Direct
389,027	2018-02-13	2024-02-24	No	4	M	Direct
382,957	2018-02-13	2024-02-24	No	4	M	Direct
344,366	2018-02-13	2024-02-24	No	4	M	Direct

Footnotes

The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2020.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2020.
All shares sold were sold at the exact price disclosed.
Twenty-five percent of the shares shall vest on each of the first, second,third, and fourth anniversaries of the vesting commencement date of February 13, 2014. Fifty percent of the vested shares shall become exercisable if, during the term of the option, the closing price of the Company's common stock is equal to or more than one-hundred and twenty-five percent of the exercise price per share for thirty consecutive trading days. The remaining fifty percent of the vested shares shall become exercisable if, after the date of award and on or before the expiration date, the closing price of the Company's common stock is equal to or more than one-hundred and fifty percent of the exercise price for 30 consecutive trading days.
Options vest and are exercisable as to 25% of the underlying grant one year after the vesting commencement date of February 13, 2014 and in equal monthly installments thereafter for three additional years.